Search Login Register

Fibrocystic Breast Disease (Chronic Cystic Mastitis) Summary

Description: A common and benign breast disease characterized by varying degree of fibrocystic changes in the breast tissue. There are three major patterns of morphological changes, including FIBROSIS, formation of CYSTS, and proliferation of glandular tissue (adenosis). The fibrocystic breast has a dense irregular, lumpy, bumpy consistency.

Also Known As: Chronic Cystic Mastitis; Mammary Dysplasia; Adenosis of Breast; Cystic Breast Disease; Cystic Disease of Breast Show All >>

Networked: 234 relevant articles (6 outcomes, 37 trials/studies) for this Disease

Key Drugs and Agents for Fibrocystic Breast Disease

Efficacy Chart >>
Drugs and Important Biological Agents (IBA) related to treatments:
  1. Danazol (Azol) : 2 outcomes 1 study in 18 results : FDA 5 Generic
  2. alpha-Tocopherol : 1 outcome 3 studies in 5 results : FDA 2
  3. Estrogens (Estrogen) : 1 outcome 2 studies in 14 results : FDA 1
  4. Lisuride : 1 outcome 1 study in 1 result : IBA
  5. Progestins (Progestagens) : 1 outcome in 3 results : IBA
  6. ovex : 1 outcome in 1 result : IBA
  7. Prolactin : 3 studies in 22 results : IBA
  8. Coffee : 3 studies in 8 results : FDA 1
  9. Caffeine (No Doz) : 2 studies in 11 results : FDA 88 Generic
  10. Progesterone : 2 studies in 10 results : FDA 11 Generic
Show All >>

Diseases Related to Fibrocystic Breast Disease

  1. Breast Neoplasms (Breast Cancer)
  2. Carcinoma (Carcinomatosis)
  3. Fibroadenoma
  4. Pain (Aches)
  5. Breast Cyst
Show All >>

Key Therapies for Fibrocystic Breast Disease

Efficacy Chart >>
  1. Ovariectomy (Oophorectomy) : 1 outcome in 2 results
  2. Fat-Restricted Diet (Diet, Fat Restricted) : 1 study in 4 results
  3. Lasers (Laser) : 1 study in 1 result
  4. Drug Therapy (Chemotherapy) : 1 study in 1 result
  5. Estrogen Replacement Therapy : 4 results
Show All >>

CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.